Principal Health Outcomes Researcher
Prime Therapeutics, LLC
Landon Marshall, Pharm.D., Ph.D., is a Principal Health Outcomes Researcher at Prime Therapeutics. Dr. Marshall’s research focuses on cell and gene therapy and the use of secondary data to predict future spending trends. His research includes cost-effectiveness analyses and evaluations of managed care services before and after implementation. Dr. Marshall also provides analytical support for value-based purchasing agreements leveraging integrated medical and pharmacy claims data.